EX-99.1 2 e4643_ex99-1.htm EXHIBIT 99.1

 

 

EXHIBIT 99.1

 

INFOBIRD CO., LTD

 Room 12A06, Block A, Boya International Center, Building 2, No. 1 Courtyard, Lize Zhongyi Road
Chaoyang District, Beijing, China 100102

 

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

To be held on May 12, 2023, at 2:00 p.m. (Local Time)
(or any adjournment or postponement thereof)

 

To the Shareholders of Infobird Co., Ltd

 

Notice is hereby given that the Extraordinary General Meeting of the Shareholders of Infobird Co., Ltd, a Cayman Islands exempted company (the “Company”) will be held on May 12, 2023, at 2:00 p.m. local time (i.e., 2:00 a.m. May 12, 2023, E.T.) at Room 12A06, Block A, Boya International Center, Building 2, No. 1 Courtyard, Lize Zhongyi Road Chaoyang District, Beijing, China 100102 (“Principal Executive Office”), and at any adjourned or postponement thereof. The Extraordinary General Meeting is called for the following purposes:

  

  1. Proposal 1: To consider and approve by an ordinary resolution that every 5 ordinary shares (the “Ordinary Shares”) of a par value of US$0.005 each in the authorized share capital of the Company (including issued and unissued share capital) be consolidated into 1 Ordinary Share of a par value of US$0.025 each with effect from May 15, 2023 (the “Share Consolidation”); such that immediately following the Share Consolidation, the authorized share capital of the Company will be US$25,000,000 divided into 1,000,000,000 shares of par value of US$0.025 each, all of which are designated as Ordinary Shares.  
     
  2. Proposal 2: To consider and approve by a special resolution the amendments of the Company’s Memorandum and Articles of Association in the form of Fourth Amended and Restated Memorandum and Articles of Association attached as Annex B hereto to reflect the above Share Consolidation; and that the Fourth Amended and Restated Memorandum and Articles of Association be adopted as the Memorandum and Articles of Association of the Company, to the exclusion of the existing Amended and Restated Memorandum and Articles of Association with effect from May 15, 2023. The registered office provider of the Company shall be instructed to file the Fourth Amended and Restated Memorandum and Articles of Association with the Registrar of Companies in the Cayman Islands and to do and complete all other matters ancillary to such filing as may be necessary or desirable in order to give effect to amendment of the Memorandum and Articles of Association in the Cayman Islands.  

 

A proxy statement providing information, and a form of proxy to vote, with respect to the foregoing matters accompany this notice. The Board of Directors of the Company fixed the close of business on April 27, 2023 as the record date (the “Record Date”) for determining the shareholders entitled to receive notice of and to vote at the Extraordinary General Meeting or any adjourned or postponement thereof. The register of members of the Company will not be closed. A list of the shareholders entitled to vote at the Extraordinary General Meeting may be examined at the Company’s offices during the 10-day period preceding the Extraordinary General Meeting.

 

i

 

 

Holders of record of the Company’s ordinary shares as of the Record Date are cordially invited to attend the Extraordinary General Meeting in person. Your vote is important. Whether or not you expect to attend the Extraordinary General Meeting in person, you are urged to complete, sign, date and return the accompanying proxy form as promptly as possible. We must receive the proxy form no later than noon (Beijing time) on the day of the Extraordinary General Meeting to ensure your representation at such meeting. Shareholders who execute proxies retain the right to revoke them at any time prior to the voting thereof, and may nevertheless vote in person at the Extraordinary General Meeting. You may obtain directions to the meeting by calling our offices at +86-010-52411819. Shareholders may obtain a copy of these materials, free of charge, by contacting the Chairman of the Board of Directors of the Company at the Principal Executive Office.

  

  By Order of the Board of Directors,
   
  /s/ Cheuk Yee Li
  Cheuk Yee Li
  Chairman of the Board of Directors
  April 28, 2023

  

IMPORTANT

 

Whether or not you expect to attend the Extraordinary General Meeting in person, you are urged to complete, sign, date and return the accompanying proxy form to ensure your representation at such meeting.

 

If your shares are held in street name, your broker, bank, custodian or other nominee holder cannot vote your shares, unless you direct the nominee holder how to vote by marking your proxy card.

 

ii

 

 

INFOBIRD CO., LTD

 TABLE OF CONTENTS

  

 

Page

Proxy Statement 1
Questions and Answers about the Extraordinary General Meeting 2
Proposal 1: To Approve a Share Consolidation 5
Proposal 2: To Approve the Fourth Amended and Restated Memorandum and Articles of Association 8
Proxy Form A-1
Fourth Amended and Restated Memorandum and Articles of Association B-1

 

iii

 

 

INFOBIRD CO., LTD

 Room 12A06, Block A, Boya International Center, Building 2, No. 1 Courtyard, Lize Zhongyi Road
Chaoyang District, Beijing, China 100102

 

PROXY STATEMENT

for

EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

 To be held on May 12, 2023 at 2:00 p.m. (Local Time)
(or any adjournment or postponement thereof)

 

PROXY SOLICITATION

 

This Proxy Statement is furnished in connection with the solicitation of proxies by the Board of Directors (the “Board” or the “Board of Directors”) of Infobird Co., Ltd (the “Company,” “we,” “us,” or “our”) for the Extraordinary General Meeting of Shareholders to be held at Room 12A06, Block A, Boya International Center, Building 2, No. 1 Courtyard, Lize Zhongyi Road Chaoyang District, Beijing, China 100102 on May 12, 2023 at 2:00 p.m. local time and for any adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Extraordinary General Meeting of Shareholders. Any shareholder giving such a proxy has the power to revoke it at any time before it is voted. Written notice of such revocation should be forwarded directly to the Chairman of the Board of Directors of the Company, at the above stated address. Proxies may be solicited through the mails or direct communication with certain shareholders or their representatives by Company officers, directors, or employees, who will receive no additional compensation therefor. You may obtain directions to the meeting by calling our offices at +86-010-52411819.

 

If the enclosed proxy is properly executed and returned, the shares represented thereby will be voted in accordance with the directions thereon and otherwise in accordance with the judgment of the persons designated as proxies. Any proxy on which no direction is specified will be voted in favor of the actions described in this Proxy Statement.

 

The Company will bear the entire cost of preparing, assembling, printing and mailing this Proxy Statement, the accompanying proxy form, and any additional material that may be furnished to shareholders. The date on which this Proxy Statement and the accompanying Proxy Form will first be mailed or given to the Company’s shareholders is on or about May 2, 2023.

 

We have elected to provide access to our proxy materials both by sending you this full set of proxy materials, including the notice of our Extraordinary General Meeting, this Proxy Statement and a proxy card to Shareholders.

 

Your vote is important. Whether or not you expect to attend the Extraordinary General Meeting in person, you are urged to complete, sign, date and return the accompanying proxy form as promptly as possible to ensure your representation at such meeting. Shareholders who execute proxies retain the right to revoke them at any time prior to the voting thereof, and may nevertheless vote in person at the Extraordinary General Meeting. If you hold your shares in street name and wish to vote your shares at the Extraordinary General Meeting, you should contact your broker, bank, custodian or other nominee holder about getting a proxy appointing you to vote your shares.

 

1

 

 

QUESTIONS AND ANSWERS ABOUT THE EXTRAORDINARY GENERAL MEETING

 

The following is information regarding the proxy material, Extraordinary General Meeting and voting is presented in a question and answer format.

  

Q. What is the purpose of this document?  
  A. This document serves as the Company’s proxy statement, including a notice of the Extraordinary General Meeting (the “Extraordinary General Meeting”) of Shareholders (the “Meeting Notice”), which is being provided to Company shareholders of record at the close of business on April 27, 2023 (the “Record Date”) because the Company’s Board of Directors is convening the Extraordinary General Meeting and soliciting shareholders’ proxies to vote at the Extraordinary General Meeting on the item of business outlined in the Meeting Notice.  
     
Q. Why am I receiving these materials?  
  A.

We have sent you this proxy statement, including the Meeting Notice and the enclosed proxy card because the Board of Directors of the Company is soliciting your proxy to vote at the Extraordinary General Meeting, including at any adjournments or postponements of the meeting. You are invited to attend the Extraordinary General Meeting to vote on the proposal described in this proxy statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card.

When you sign the enclosed proxy card, you appoint the proxy holder as your representative at the meeting. The proxy holder will vote your shares as you have instructed in the proxy card, thereby ensuring that your shares will be voted whether or not you attend the meeting. Even if you plan to attend the meeting, you should complete, sign and return your proxy card in advance of the meeting just in case your plans change.

If you have signed and returned the proxy card and an issue comes up for a vote at the meeting that is not identified on the card, the proxy holder will vote your shares, pursuant to your proxy, in accordance with his or her judgment.

  
The Company intends to mail this proxy statement and accompanying proxy card on or about May 2, 2023 to all shareholders entitled to vote at the Extraordinary General Meeting.  

 

Q. Who may vote and how many votes my I cast?  
  A. Only shareholders of record on the Record Date, April 27, 2023, will be entitled to vote at the Extraordinary General Meeting. On the Record Date, there were 22,939,315 ordinary shares outstanding and entitled to vote. Each ordinary share is entitled to one vote on each matter. There are no preferred shares issued and outstanding.

 

Q. How do I vote?  
  A. You may vote “For” or “Against” the proposals, or “Abstain” from voting on such proposals. The procedures for voting are outlined below:  

 

2

 

 

Shareholder of Record: Shares Registered in Your Name

 

If you are a shareholder of record, you may vote in person at the Extraordinary General Meeting or vote by proxy using the enclosed proxy card.

  

  To vote in person, come to the Extraordinary General Meeting and we will give you a ballot when you arrive; or
  To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us by 11:59 p.m. EDT before the day of the Extraordinary General Meeting, we will vote your shares as you direct.

 

Beneficial Owner: Shares Registered in the Name of a Broker, Bank, Custodian or Other Nominee Holder

 

If you received this proxy statement from your broker, bank, custodian or other nominee holder, your broker, bank, custodian or other nominee holder should have given you instructions for directing how that person or entity should vote your shares. It will then be your broker, bank, custodian or other nominee holder’s responsibility to vote your shares for you in the manner you direct. Please complete, execute and return the proxy card in the envelope provided by your broker, bank, custodian or other nominee holder promptly.

 

Under the rules of various national and regional securities exchanges, brokers generally may vote on routine matters, such as the ratification of the engagement of an independent public accounting firm, but may not vote on non-routine matters unless they have received voting instructions from the person for whom they are holding shares. The proposals are non-routine matters and, consequently, your broker, bank, custodian or other nominee holder will not have discretionary authority to vote your shares on these matters. If your broker, bank, custodian or other nominee holder does not receive instructions from you on how to vote on this matter, your broker, bank, custodian or other nominee holder will return the proxy card to us, indicating that he or she does not have the authority to vote on these matters. This is generally referred to as a “broker non-vote” and may affect the outcome of the voting.

 

We therefore encourage you to provide directions to your broker, bank, custodian or other nominee holder as to how you want your shares voted on all matters to be brought before the Extraordinary General Meeting. You should do this by carefully following the instructions your broker, bank, custodian or other nominee holder gives you concerning its procedures. This ensures that your shares will be voted at the Extraordinary General Meeting.

 

You are also invited to attend the Extraordinary General Meeting. However, since you are not the shareholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker, bank, custodian or other nominee holder.

  

Q. What if I change my mind after I vote via proxy?  
   
  A. If you hold your shares in your own name, you may revoke your proxy at any time before your shares are voted by:

 

     mailing a later dated proxy prior to the Extraordinary General Meeting;
     
     delivering a written request in person to return the executed proxy;
     
     voting in person at the Extraordinary General Meeting; or
     
    providing written notice of revocation to the Chairman of the Board of Directors of the Company at: Room 12A06, Block A, Boya International Center, Building 2, No. 1 Courtyard, Lize Zhongyi Road Chaoyang District, Beijing, China 100102.  

 

If you hold your shares in the name of your broker, bank, or other fiduciary, you will need to contact that person or entity to revoke your proxy.

 

3

 

 

Q. What does it mean if I receive more than one proxy card or voting instruction form?  
   
  A. It means that you have multiple accounts at our transfer agent or with brokers, banks, or other fiduciaries. Please complete and return all proxy cards and voting instruction forms to ensure that all of your shares are voted.

 

Q. How many shares must be present to hold a valid meeting?  
   
  A. For us to hold a valid Extraordinary General Meeting, we must have a quorum of the shareholders holding not less than one-third in nominal value of our total issued voting shares that are entitled to vote upon the business to be transacted. Proxies received but marked as abstentions and Broker Non-Votes will be treated as shares that are present and entitled to vote for purposes of determining a quorum. Your shares will be counted as present at the Extraordinary General Meeting if you:
     
    properly submit a proxy card (even if you do not provide voting instructions); or
       
    attend the Meeting and vote in person.  

 

On April 27, 2023, the Record Date, there were 22,939,315 ordinary shares outstanding. Therefore, at least 7,646,439 (one third of the outstanding ordinary shares) shares need to be present in person or by proxy at the Extraordinary General Meeting in order to hold the meeting and conduct business.

  

Q.

How many votes are required to approve an item of business?

   

  Assuming a quorum as referenced above is reached –  
   
  A. Proposal 1 will be approved if passed by a simple majority of the shareholders being entitled to do so, voting in person or by proxy at the Extraordinary General Meeting.  
    Proposal 2 will be approved if passed by a majority of not less than two-thirds of the shareholders being entitled to do so, voting in person or by proxy at the Extraordinary General Meeting.  

 

Only shares that are voted are taken into account in determining the proportion of votes cast for the proposals. Any shares not voted (whether by abstention, broker non-vote or otherwise) will not impact any of the votes.

  

Q. Who pays the cost for soliciting proxies?  
   
  A. We will pay the cost for the solicitation of proxies by the Board of Directors. Our solicitation of proxies will be made primarily by mail. Proxies may also be solicited personally, by telephone, fax or e-mail by our officers, directors, and regular supervisory and executive employees, none of whom will receive any additional compensation for their services. We will also reimburse brokers, banks, custodians, other nominees and fiduciaries for forwarding these materials to beneficial holders to obtain the authorization for the execution of proxies.  
     
Q. Where can I find additional information about the Company?  
   
  A. Our reports on 6-K, and other publicly available information, should be consulted for other important information about the Company. You can also find additional information about us on our web site at https://www.infobird.com. The mailing address and the location of the principal executive office of the Company is Room 12A06, Block A, Boya International Center, Building 2, No. 1 Courtyard, Lize Zhongyi Road Chaoyang District, Beijing, China 100102.  

 

4

 

 

Proposal 1

 

AUTHORIZE THE BOARD OF DIRECTORS TO EFFECT A SHARE CONSOLIDATION

 

Purpose and Background of the Share Consolidation

 

To consider and approve by an ordinary resolution that every 5 ordinary shares (the “Ordinary Shares”) of a par value of US$0.005 each in the authorized share capital of the Company (including issued and unissued share capital) be consolidated into 1 Ordinary Share of a par value of US$0.025 each with effect from May 15, 2023 (the “Share Consolidation”); such that immediately following the Share Consolidation, the authorized share capital of the Company will be US$25,000,000 divided into 1,000,000,000 shares of par value of US$0.025 each, all of which are designated as Ordinary Shares.

 

On April 26, 2023, the Board of Directors approved by written resolution of the Directors the proposal authorizing the Share Consolidation because the Board of Directors believes that effecting the Share Consolidation could, in some circumstances, be an effective means of maintaining, or if necessary, regaining, compliance with the minimum trading price requirement for continued listing of our Ordinary Shares on The Nasdaq Capital Market.

 

On December 6, 2022, the Company received a letter from The Nasdaq Stock Market regarding the Company’s failure to comply with Nasdaq Continued Listing Rule (“Rules”) 5550(a)(2) (the “Price Rule”), which requires listed securities to maintain a minimum bid price of $1.00 per share. A failure to comply with Rule 5550(a)(2) exists when listed securities fail to maintain a closing bid price of at least $1.00 per share for 30 consecutive business days.

 

Under Rule 5810(c)(3)(A), the Company was provided a compliance period of 180 calendar days, until June 5, 2023, to regain compliance. If at any time during this 180 day period the closing bid price of the Company’s securities is at least $1.00 for a minimum of ten consecutive business days, the Company’s compliance will be regained.

 

To regain compliance, the bid price of the Company’s Ordinary Shares must close at or above $1.00 per share for a minimum of ten consecutive business days at any time during the second 180-day compliance period. The Company has been monitoring the closing bid price of its Ordinary Shares and now considers effecting the Share Consolidation.

 

If the Share Consolidation successfully increases the per share price of our Ordinary Shares, the Board of Directors believes this Share Consolidation will enable us to maintain The Nasdaq Capital Market listing of our Ordinary Shares.

 

If we again cease to comply with the minimum per share average closing price standard of Price Rule and fail to regain compliance by the end of the 180 day cure period, or June 5, 2023, our Ordinary Shares will be subject to delisting by the Nasdaq Stock Market. In the event that our Ordinary are delisted by the Nasdaq Stock Market, our Ordinary Shares would likely trade on the over-the-counter market. If our stocks were to trade on the over-the-counter market, selling our Ordinary Shares could be more difficult because smaller quantities of stocks would likely be bought and sold, and transactions could be delayed. In addition, in the event our Ordinary Shares are delisted, broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers from effecting transactions in our Ordinary Shares, further limiting the liquidity of our Ordinary Shares. These factors could result in lower prices and larger spreads in the bid and ask prices for Ordinary Shares. Such potential delisting from the Nasdaq and continued or further declines in our share price could also greatly impair our ability to raise additional necessary capital through equity or debt financing, including short-term debt financing provided by foreign lenders.

 

In light of the factors mentioned above, our Board of Directors approved this proposal as a potential means of maintaining the price of our Ordinary Shares above $1.00 per share in compliance with Price Rule.

 

5

 

 

Potential Affected Investor Interest

 

In approving this proposal, the Board of Directors considered that the Company’s Ordinary Shares may not appeal to brokerage firms that are reluctant to recommend lower priced securities to their clients. Investors may also be dissuaded from purchasing lower priced stocks because the brokerage commissions, as a percentage of the total transaction, tend to be higher for such stocks. Moreover, the analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage of lower priced stocks.

 

By approving this proposal, shareholders will approve the Company to effect a Share Consolidation which it deems in the best interests of the Company and its shareholders.

 

Principal Effects of the Share Consolidation

 

If implemented, the Share Consolidation will be effected simultaneously for all shares of the Company (both issued and unissued). The Share Consolidation will affect all of our shareholders uniformly and will not affect any shareholder’s percentage ownership interests in the Company, except to the extent that in the case where the Share Consolidation would otherwise result in any of our shareholders owning a fractional share, the fractional number of shares held by such shareholders will be rounded up to the next whole number. After the Share Consolidation, the shares of our Ordinary Shares will have the same voting rights and rights to dividends and distributions and will be identical in all other respects to our Ordinary Shares now authorized. Ordinary Shares issued pursuant to the Share Consolidation will remain fully paid and non-assessable. The Share Consolidation will not affect the Company continuing to be subject to the periodic reporting requirements of the Exchange Act. The Share Consolidation is not intended to be, and will not have the effect of, a “going private transaction” covered by Rule 13e-3 under the Exchange Act.

 

The Share Consolidation may result in some shareholders owning “odd-lots” of less than 100 shares of our Ordinary Shares. Brokerage commissions and other costs of transactions in odd-lots are generally higher than the costs of transactions in “round-lots” of even multiples of 100 shares.

 

Following the effectiveness of such Share Consolidation approved by the shareholders and implementation by the Board of Directors, current shareholders will hold fewer shares of Ordinary Shares, but the rights and ownership percentages will remain the same.

 

IF THIS PROPOSAL IS NOT APPROVED, WE MAY BE UNABLE TO MAINTAIN THE LISTING OF OUR ORDINARY SHARES ON THE NASDAQ STOCK MARKET, WHICH COULD ADVERSELY AFFECT THE LIQUIDITY AND MARKETABILITY OF OUR ORDINARY SHARES.

 

Fractional Shares

 

No fractional shares will be issued in connection with the Share Consolidation. Instead, we will issue one full share of the Ordinary Shares after Share Consolidation to any shareholder who would have been entitled to receive a fractional share as a result of the Share Consolidation. Each ordinary shareholder will hold the same percentage of the outstanding Ordinary Shares immediately following the Share Consolidation as that shareholder did immediately prior to the Share Consolidation, except for minor adjustments due to the additional net share fractions that will need to be issued as a result of the treatment of fractional shares.

 

6

 

 

Risks Associated with the Share Consolidation

 

There are risks associated with the Share Consolidation. Shareholders should note that the effect of the Share Consolidation, if any, upon the market price for our Ordinary Shares cannot be accurately predicted. In particular, we cannot assure you that prices for shares of our Ordinary Shares after the Share Consolidation will be the number of times equals exactly to the ratio multiplied by the prices for shares of our Ordinary Shares immediately prior to the Share Consolidation. Furthermore, even if the market price of our Ordinary Shares does rise following the Share Consolidation, we cannot assure you that the market price of our Ordinary Shares immediately after the proposed Share Consolidation will be maintained for any period of time. Even if an increased per-share price can be maintained, the Share Consolidation may not achieve the desired results that have been outlined above. Moreover, because some investors may view the Share Consolidation negatively, we cannot assure you that the Share Consolidation will not adversely impact the market price of our Ordinary Shares.

 

The market price of our Ordinary Shares will also be based on our performance and other factors, some of which are unrelated to the Share Consolidation or the number of shares outstanding. If the Share Consolidation is effected and the market price of our Ordinary Shares declines, the percentage declines as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of a Share Consolidation. The total market capitalization of our Ordinary Shares after implementation of the Share Consolidation, when and if implemented, may also be lower than the total market capitalization before the Share Consolidation. Furthermore, the liquidity of our Ordinary Shares could be adversely affected by the reduced number of shares that would be outstanding after the Share Consolidation.

 

While we believe that the Share Consolidation will be sufficient to maintain our listing on The Nasdaq Stock Market, it is possible that, even if the Share Consolidation results in a closing price for our Ordinary Shares that exceeds $1.00 per share, we may not be able to continue to satisfy other criteria for continued listing of our Ordinary Shares on The Nasdaq Stock Market. Although we believe that we will continue satisfying all of the other continued listing criteria, we cannot assure you that this will be the case.

 

Vote Required to Approve Proposal 1

 

The Proposal 1 will be approved only if it receives the affirmative vote of at least a simple majority of the shareholders being entitled to do so, voting in person or by proxy at the Extraordinary General Meeting assuming a quorum reaches.

 

WE RECOMMEND A VOTE “FOR” THE PROPOSAL TO AUTHORIZE THE BOARD OF DIRECTORS TO EFFECT THE SHARE CONSOLIDATION

 

7

 

 

Proposal 2

 

To Approve the fourth Amended and Restated Memorandum and Articles of Association

 

To consider and approve by a special resolution the amendments of the Company’s Memorandum and Articles of Association in the form of Fourth Amended and Restated Memorandum and Articles of Association attached as Annex B hereto to reflect the above Share Consolidation; and that the Fourth Amended and Restated Memorandum and Articles of Association be adopted as the Memorandum and Articles of Association of the Company, to the exclusion of the existing Memorandum and Articles of Association with effect from May 15, 2023. The registered office provider of the Company shall be instructed to file the Fourth Amended and Restated Memorandum and Articles of Association with the Registrar of Companies in the Cayman Islands and to do and complete all other matters ancillary to such filing as may be necessary or desirable in order to give effect to amendment of the Memorandum and Articles of Association in the Cayman Islands.

 

Vote Required to Approve Proposal 2

 

Proposal 2 will be approved only if it receives the affirmative vote of a majority of not less than two-thirds of the shareholders being entitled to do so, voting in person or by proxy at the Extraordinary General Meeting assuming a quorum reaches.

 

WE RECOMMEND A VOTE “FOR” THE PROPOSAL TO APPROVE TO AMEND AND RESTATE THE Memorandum and Articles of Association

 

8

 

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our ordinary shares is VStock Transfer, LLC. Its address is 18 Lafayette Place, Woodmere, New York 11598, and its telephone number is +1 (212) 828-8436.

 

Where You Can Find More Information

 

We file annual report and other documents with the SEC under the Exchange Act. Our SEC filings made electronically through the SEC’s EDGAR system are available to the public at the SEC’s website at http://www.sec.gov. You may also read and copy any document we file with the SEC at the SEC’s public reference room located at 100 F Street, NE, Room 1580, Washington, DC 20549. Please call the SEC at +1 (800) SEC-0330 for further information on the operation of the public reference room.

 

  By Order of the Board of Directors,
   
  /s/ Cheuk Yee Li
  Cheuk Yee Li
  Chairman of the Board

   

April 28, 2023

 

9

 

 

ANNEX A

 

Form of Proxy Card

 

A-1

 

 

ANNEX B

 

Form of Fourth Amended and Restated Memorandum and Articles of Association

 of

Infobird Co., Ltd

 

B-1